Insider Transactions in Q1 2025 at Myomo, Inc. (MYO)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 14
2025
|
Micah Mitchell Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
48,000
-25.45%
|
$240,000
$5.16 P/Share
|
|
Mar 13
2025
|
Thomas F Kirk |
BUY
Open market or private purchase
|
Direct |
7,400
+2.81%
|
$37,000
$5.0 P/Share
|
|
Mar 13
2025
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,496
-1.53%
|
$7,480
$5.22 P/Share
|
|
Mar 13
2025
|
David A Henry Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,019
-0.52%
|
$10,095
$5.22 P/Share
|
|
Mar 13
2025
|
Micah Mitchell Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,283
-0.68%
|
$6,415
$5.22 P/Share
|
|
Mar 12
2025
|
Harry Kovelman Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
30,000
-23.44%
|
$150,000
$5.5 P/Share
|
|
Mar 11
2025
|
Harry Kovelman Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,553
+2.7%
|
-
|
|
Mar 11
2025
|
David A Henry Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,106
+1.05%
|
-
|
|
Mar 11
2025
|
Paul R Gudonis Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,708
+0.65%
|
-
|
|
Feb 13
2025
|
Paul R Gudonis Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
694
+0.07%
|
$0
$0.05 P/Share
|